Martine J. Jager

15.6k citations

311 papers · 9.4k indexed · 3 hit papers · h-index 50

Ophthalmology top 0.02%
- Ocular Oncology and Treatments 180
- Glaucoma and retinal disorders 22
Immunology top 0.5%
- Immunotherapy and Immune Responses 112
- T-cell and B-cell Immunology 27
Oncology top 0.5%
- Cutaneous Melanoma Detection and Management 27
Radiology, Nuclear Medicine and Imaging top 1%
- Corneal Surgery and Treatments 45
Molecular Biology top 2%
- Retinal Development and Disorders 27
Immunology and Allergy
- Cell Adhesion Molecules Research 21

Co-authors: Gregorius P. M. Luyten Pieter A. van der Velden Inge H. G. Bronkhorst Ekaterina S. Jordanova Long V. Ly Mehmet Doğrusöz Willem Maat Nelleke A. Gruis
Cited by: Ophthalmology Immunology Oncology
Journals: Journal of Clinical Oncology (2 papers)SHILAP Revista de lepidopterología (5 papers)The Journal of Immunology (10 papers)
Partner nations: Netherlands United States United Kingdom

In The Last Decade

Martine J. Jager

305 papers receiving 9.2k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2023 Nature Reviews Clinical Oncology
2023 Pharmaceutics
2020 Nature Reviews Disease Primers

Peers

Countries citing papers authored by Martine J. Jager

Since Specialization

Citations

This map shows the geographic impact of Martine J. Jager's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martine J. Jager with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martine J. Jager more than expected).

Fields of papers citing papers by Martine J. Jager

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martine J. Jager. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martine J. Jager. The network helps show where Martine J. Jager may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Martine J. Jager, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Martine J. Jager Line = papers co-authored together Martine J. Jager links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Survival in Patients with Uveal Melanoma Is Linked to Genetic Variation at HERC2 Single Nucleotide Polymorphism rs12913832 Ophthalmology ·Maria Chiara Gelmi,Laurien E. Houtzagers,Annemijn P. A. Wierenga,Mieke Versluis,Bastiaan T. Heijmans,Gregorius P. M. Luyten,Peter de Knijff,Marije te Raa,Rick H. de Leeuw,Martine J. Jager	2024	0
2	Uveal melanoma: Current evidence on prognosis, treatment and potential developments Asia-Pacific Journal of Ophthalmology ·Maria Chiara Gelmi,Martine J. Jager	2024	14
3	PRAME Expression: A Target for Cancer Immunotherapy and a Prognostic Factor in Uveal Melanoma Investigative Ophthalmology & Visual Science ·Maria Chiara Gelmi,Gülçin Gezgin,Pieter A. van der Velden,Gregorius P. M. Luyten,Sietse J. Luk,Mirjam H.M. Heemskerk,Martine J. Jager	2023	12
4	High C-Reactive Protein Levels Are Related to Better Survival in Patients with Uveal Melanoma SHILAP Revista de lepidopterología ·Nikki Meijer,Daniël P. de Bruyn,Annelies de Klein,Dion Paridaens,Robert M. Verdijk,Tos T. J. M. Berendschot,Erwin Brosens,Martine J. Jager,Emine Kılıç	2022	2
5	Involvement of mutant and wild-type CYSLTR2 in the development and progression of uveal nevi and melanoma BMC Cancer ·Rogier J. Nell,Nino V. Menger,Mieke Versluis,Gregorius P. M. Luyten,Robert M. Verdijk,Michele C. Madigan,Martine J. Jager,Pieter A. van der Velden	2021	23
6	In Uveal Melanoma, Angiopoietin-2 but Not Angiopoietin-1 Is Increased in High-Risk Tumors, Providing a Potential Druggable Target Cancers ·Anna M.W. ten Voorde,Annemijn P. A. Wierenga,Rogier J. Nell,Pieter A. van der Velden,Gregorius P. M. Luyten,Robert M. Verdijk,Martine J. Jager	2021	3
7	Expression of HDACs 1, 3 and 8 Is Upregulated in the Presence of Infiltrating Lymphocytes in Uveal Melanoma Cancers ·Zahra Souri,Aart G. Jochemsen,Annemijn P. A. Wierenga,Wilma G. M. Kroes,Robert M. Verdijk,Pieter A. van der Velden,Gregorius P. M. Luyten,Martine J. Jager	2021	9
8	Five Decades of Enucleations for Uveal Melanoma in One Center: More Tumors with High Risk Factors, No Improvement in Survival over Time Ocular Oncology and Pathology ·Christine D.M. Roelofsen,Annemijn P. A. Wierenga,Sjoerd G. van Duinen,Robert M. Verdijk,Jaco C. Bleeker,Marina Marinkovic,Gregorius P. M. Luyten,Martine J. Jager	2020	18
9	Families with BAP1-Tumor Predisposition Syndrome in The Netherlands: Path to Identification and a Proposal for Genetic Screening Guidelines Cancers ·Cindy Chau,Remco van Doorn,Natasha M. van Poppelen,Nienke van der Stoep,Arjen R. Mensenkamp,Rolf H. Sijmons,Barbara W. van Paassen,Ans M.W. van den Ouweland,Nicole C. Naus,Annemieke H. van der Hout,Thomas P. Potjer,Fonnet E. Bleeker,Marijke R. Wevers,Liselotte P. van Hest,Marjolijn C.J. Jongmans,Marina Marinkovic,Jaco C. Bleeker,Martine J. Jager,Gregorius P. M. Luyten,Maartje Nielsen	2019	39
10	Secondary Somatic Mutations in G-Protein-Related Pathways and Mutation Signatures in Uveal Melanoma Cancers ·Francesca Piaggio,Veronica Tozzo,Cinzia Bernardi,Michela Croce,Roberto Puzone,Silvia Viaggi,Serena Patrone,Annalisa Barla,Domenico Coviello,Martine J. Jager,Pieter A. van der Velden,Michael Zeschnigk,Davide Cangelosi,Alessandra Eva,Ulrich Pfeffer,Adriana Amaro	2019	22
11	Do GNAQ and GNA11 Differentially Affect Inflammation and HLA Expression in Uveal Melanoma? Cancers ·Christiaan van Weeghel,Annemijn P. A. Wierenga,Mieke Versluis,Thorbald van Hall,Pieter A. van der Velden,Wilma G. M. Kroes,Ulrich Pfeffer,Gregorius P. M. Luyten,Martine J. Jager	2019	11
12	Neuroinflammation and microglia in glaucoma: time for a paradigm shift Journal of Neuroscience Research ·Xin Wei,Kin‐Sang Cho,Eric F. Thee,Martine J. Jager,Dong Feng Chen	2018	156
13	Digital PCR-Based T-cell Quantification–Assisted Deconvolution of the Microenvironment Reveals that Activated Macrophages Drive Tumor Inflammation in Uveal Melanoma Molecular Cancer Research ·Mark J. de Lange,Rogier J. Nell,Rajshri N. Lalai,Mieke Versluis,Ekaterina S. Jordanova,Gré P.M. Luyten,Martine J. Jager,Sjoerd H. van der Burg,Willem H. Zoutman,Thorbald van Hall,Pieter A. van der Velden	2018	33
14	PRAME as an Independent Biomarker for Metastasis in Uveal Melanoma Clinical Cancer Research ·Matthew G. Field,Christina L. Decatur,Stefan Kurtenbach,Gülçin Gezgin,Pieter A. van der Velden,Martine J. Jager,Kaleigh N. Kozak,J. William Harbour	2016	196
15	Uveal Melanoma Cell Lines: Where do they come from? (An American Ophthalmological Society Thesis). PubMed ·Martine J. Jager,J. Antonio Bermudez Magner,Bruce R. Ksander,Sander R. Dubovy	2016	73
16	A fish scale-derived scaffold for corneal reconstruction Investigative Ophthalmology & Visual Science ·TH VAN ESSEN,SARAH J. SPARKS,L. van Zijl,Greg Chen,Chien Chin Lin,Horng J. Lai,Gregorius P. M. Luyten,Abdoelwaheb El Ghalbzouri,Martine J. Jager	2013	1
17	Peptide Vaccination after T-Cell Transfer Causes Massive Clonal Expansion, Tumor Eradication, and Manageable Cytokine Storm Cancer Research ·Long V. Ly,Marjolein Sluijter,Mieke Versluis,Gré P.M. Luyten,Sjoerd H. van der Burg,Cornelis J.M. Melief,Martine J. Jager,Thorbald van Hall	2010	40
18	Triamcinolone acetonide and anecortave acetate do not stimulate uveal melanoma cell growth. PubMed ·Mariam el Filali,Irene Homminga,Willem Maat,Pieter A. van der Velden,Martine J. Jager	2008	14
19	Expression of epidermal growth factor receptor: risk factor in uveal melanoma. PubMed ·H. M. H. Hurks,Jessica A.W. Metzelaar-Blok,E. R. Barthen,A. H. Zwinderman,D. de Wolff–Rouendaal,J. E. E. Keunen,Martine J. Jager	2000	35
20	Keimemissionen im Umfeld von Kompostierungsanlagen TUbilio (Technical University of Darmstadt) ·Cornelia Eckrich,Martine J. Jager,(unknown)	1996	1

About Martine J. Jager

Martine J. Jager is a scholar working on Ophthalmology, Immunology and Immunology and Allergy, having authored 311 papers that have together received 9.4k indexed citations. Recurring topics across this work include Ocular Oncology and Treatments (180 papers), Immunotherapy and Immune Responses (112 papers), Corneal Surgery and Treatments (45 papers), Cutaneous Melanoma Detection and Management (27 papers), T-cell and B-cell Immunology (27 papers), Retinal Development and Disorders (27 papers), Glaucoma and retinal disorders (22 papers) and Cell Adhesion Molecules Research (21 papers). The work is most often cited by research in Ophthalmology (5.8k citations), Immunology (3.4k citations) and Oncology (2.7k citations). Martine J. Jager has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Gregorius P. M. Luyten, Pieter A. van der Velden, Inge H. G. Bronkhorst, Ekaterina S. Jordanova, Long V. Ly, Mehmet Doğrusöz, Willem Maat, Nelleke A. Gruis, Mieke Versluis and Hans E. Grossniklaus. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact